ABB has been awarded an order from GE Healthcare’s Life Science division in Uppsala, Sweden, worth approximately $4 million, for automation systems to be used in the production of protein separation media. The automation systems are part of the development of a new production plant to meet the increasing demand for separation media based on agarose and dextran.
The automation, using ABB’s IndustrialIT 800xA (extended Automation) system, provides control and monitoring of tanks and reactors, batch control plus control functions for automatic valves, stirrers and analogue measurement signals for the process. The systems also include functions for the assembling and handling process, operational data management with functions for reporting and archiving.
This project will also take advantage of the ABB PCEquipment Library, a generic, re-usable software suite for batch applications that breaks new ground by distributing the control intelligence throughout the control hierarchy, thus enabling truly generic, pre-tested and re-usable library objects to be provided for units, equipment modules and phases. This makes specification, implementation and configuration of control systems less complex and less time consuming. It enables, in many cases, process engineers to change recipes rather than require configuration engineer specialists for the task.
The systems comprise about 4000I/O signals, of which 75% will be handled by ABB's distributed I/O-channels S900 which will be mounted in Ex-classified areas along with local operator workplaces.
The order is the third from GE Healthcare in Uppsala to ABB for automation equipment, including a System 800xA for different production purposes.
Previous experience with 800xA and ABB's project handling capability determined the selection of the systems. This also gives GE the flexibility of making it easier for the operators to work with the same operator interface for different plant areas.
The system is scheduled to be in operation in later this year.
For more information on this company click here
To add your company click here
Red Bull makes hydrogen fuel cell play with AVL
Formula 1 is an anachronistic anomaly where its only cutting edge is in engine development. The rules prohibit any real innovation and there would be...